TY - JOUR
T1 - Therapies Aimed at the Gut Microbiota and Inflammation
T2 - Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies
AU - Quigley, Eamonn M.M.
N1 - Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2011/3
Y1 - 2011/3
N2 - Several recent observations have raised the possibility that disturbances in the gut microbiota and/or a low-grade inflammatory state may contribute to symptomatology and the etiology of irritable bowel syndrome (IBS). Consequent on these hypotheses, several therapeutic categories have found their way into the armamentarium of those who care for IBS sufferers. These agents include probiotics, prebiotics, antibiotics, and anti-inflammatory agents.
AB - Several recent observations have raised the possibility that disturbances in the gut microbiota and/or a low-grade inflammatory state may contribute to symptomatology and the etiology of irritable bowel syndrome (IBS). Consequent on these hypotheses, several therapeutic categories have found their way into the armamentarium of those who care for IBS sufferers. These agents include probiotics, prebiotics, antibiotics, and anti-inflammatory agents.
KW - Anti-inflammatories
KW - Antibiotics
KW - Gut microbiota
KW - Prebiotics
KW - Synbiotics
UR - http://www.scopus.com/inward/record.url?scp=79951570315&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79951570315&partnerID=8YFLogxK
U2 - 10.1016/j.gtc.2010.12.009
DO - 10.1016/j.gtc.2010.12.009
M3 - Review article
C2 - 21333908
AN - SCOPUS:79951570315
VL - 40
SP - 207
EP - 222
JO - Gastroenterology Clinics of North America
JF - Gastroenterology Clinics of North America
SN - 0889-8553
IS - 1
ER -